Document is current
Any future updates will be listed below
-
Authors
Varenna, Massimo https://orcid.org/0000-0002-8644-0909
Orsini, Francesco
Di Taranto, Raffaele
Zucchi, Francesca
Adami, Giovanni
Gatti, Davide
Crotti, Chiara
-
Funding
Funding for this research was provided by:
Abiogen Pharma spa
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 18 June 2024
First Online: 1 July 2024
Declarations
:
: M. Varenna received advisory board honoraria, consultancy fees, and/or speaker fees from Accord, UCB, and Sandoz. D. Gatti has received advisory board honoraria, consultancy fees, and/or speaker fees from Accord, Amgen, Neopharmed Gentili, and UCB. F. Orsini, R. Di Taranto, F. Zucchi, G. Adami, D. Gatti, and C. Crotti have no conflict of interest to declare.
